Andrea L. Roberts, PhD; Jessica C. Agnew-Blais, ScD; Donna Spiegelman, ScD; et al.
free access
JAMA Psychiatry. 2015;72(3):203-210. doi:10.1001/jamapsychiatry.2014.2632
This 22-year longitudinal study reports that women with highest number of symptoms of posttraumatic stress disorder had a nearly 2-fold increased risk of type 2 diabetes mellitus over follow-up than women with no trauma exposure.
Kenneth S. Kendler, MD; Jianguang Ji, PhD; Alexis C. Edwards, PhD; et al.
free access
JAMA Psychiatry. 2015;72(3):211-218. doi:10.1001/jamapsychiatry.2014.2138
This cohort study using 8 public data registers reports that parent-offspring transmission of alcohol use disorder results from both genetic and environmental factors.
Jordan E. DeVylder, PhD; Ellen P. Lukens, PhD, MSW; Bruce G. Link, PhD; et al.
free access
JAMA Psychiatry. 2015;72(3):219-225. doi:10.1001/jamapsychiatry.2014.2663
This logistic regression study found that assessment of psychotic experiences among suicidal individuals has the potential to reduce the prevalence of suicide attempts.
Tyler A. Lesh, PhD; Costin Tanase, PhD; Benjamin R. Geib, MS; et al.
free access
JAMA Psychiatry. 2015;72(3):226-234. doi:10.1001/jamapsychiatry.2014.2178
This case-control cross-sectional study finds that short-term treatment with antipsychotics was associated with prefrontal cortical thinning, but that treatment was associated with better cognitive control and increased prefrontal functional activity.
Susan L. McElroy, MD; James I. Hudson, MD, ScD; James E. Mitchell, MD; et al.
free access
JAMA Psychiatry. 2015;72(3):235-246. doi:10.1001/jamapsychiatry.2014.2162
This randomized, double-blind, parallel-group, forced-dose titration, placebo-controlled clinical trial demonstrates efficacy for the 50- and 70-mg/d dosages of lisdexamfetamine dimesylate compared with placebo for treatment of binge-eating disorder.
Jesse R. Fann, MD, MPH; Charles H. Bombardier, PhD; J. Scott Richards, PhD; et al.
free access
JAMA Psychiatry. 2015;72(3):247-258. doi:10.1001/jamapsychiatry.2014.2482
This multisite, randomized clinical trial finds that venlafaxine XR was well tolerated by most patients and an effective antidepressant for decreasing core symptoms of depression and improving spinal cord injury–related disability.
David P. G. van den Berg, MSc; Paul A. J. M. de Bont, MSc; Berber M. van der Vleugel, MSc; et al.
free access
JAMA Psychiatry. 2015;72(3):259-267. doi:10.1001/jamapsychiatry.2014.2637
This single-blind randomized clinical trial finds that standard prolonged exposure and eye movement desensitization and reprocessing protocols are effective, safe, and feasible in patients with PTSD and severe psychotic disorders, including current symptoms.
Elaine Setiawan, PhD; Alan A. Wilson, PhD; Romina Mizrahi, MD, PhD; et al.
free access
JAMA Psychiatry. 2015;72(3):268-275. doi:10.1001/jamapsychiatry.2014.2427
This case-control study finds evidence of inflammation of the anterior cingular cortex in major depressive episodes (MDE).
Peter Szatmari, MD; Stelios Georgiades, PhD; Eric Duku, PhD; et al.
free access
JAMA Psychiatry. 2015;72(3):276-283. doi:10.1001/jamapsychiatry.2014.2463
The findings of this large Canadian multisite longitudinal study confirm the heterogeneous nature of developmental trajectories in autism spectrum disorder,
Robert H. Pietrzak, PhD, MPH; Yen Ying Lim, PhD; Alexander Neumeister, MD; et al.
free access
JAMA Psychiatry. 2015;72(3):284-291. doi:10.1001/jamapsychiatry.2014.2476
This multicenter, prospective cohort study provides support for the deleterious effect of elevated amyloid-β levels on cognitive function in preclinical Alzheimer disease.